Literature DB >> 31896670

Grafting Embryonic Raphe Neurons Reestablishes Serotonergic Regulation of Sympathetic Activity to Improve Cardiovascular Function after Spinal Cord Injury.

Shaoping Hou1, Tatiana M Saltos2, Eugene Mironets2, Cameron T Trueblood2, Theresa M Connors2, Veronica J Tom1.   

Abstract

Cardiovascular dysfunction often occurs after high-level spinal cord injury. Disrupting supraspinal vasomotor pathways affects basal hemodynamics and contributes to the development of autonomic dysreflexia (AD). Transplantation of early-stage neurons to the injured cord may reconstruct the descending projections to enhance cardiovascular performance. To determine the specific role of reestablishing serotonergic regulation of hemodynamics, we implanted serotonergic (5-HT+) neuron-enriched embryonic raphe nucleus-derived neural stem cells/progenitors (RN-NSCs) into a complete spinal cord transection lesion site in adult female rats. Grafting embryonic spinal cord-derived NSCs or injury alone served as 2 controls. Ten weeks after injury/grafting, histological analysis revealed well-survived grafts and partial integration with host tissues in the lesion site. Numerous graft-derived serotonergic axons topographically projected to the caudal autonomic regions. Neuronal tracing showed that host supraspinal vasomotor pathways regenerated into the graft, and 5-HT+ neurons within graft and host brainstem neurons were transsynaptically labeled by injecting pseudorabies virus (PRV-614) into the kidney, indicating reconnected serotonergic circuits regulating autonomic activity. Using an implanted telemeter to record cardiovascular parameters, grafting RN-NSCs restored resting mean arterial pressure to normal levels and remarkably alleviated naturally occurring and colorectal distension-induced AD. Subsequent pharmacological blockade of 5-HT2A receptors with ketanserin in RN-NSC-grafted rats reduced resting mean arterial pressure and increased heart rate in all but 2 controls. Furthermore, spinal cord retransection below RN-NSC grafts partially eliminated the recovery in AD. Collectively, these data indicate that RN-NSCs grafted into a spinal cord injury site relay supraspinal control of serotonergic regulation for sympathetic activity to improve cardiovascular function.SIGNIFICANCE STATEMENT Disruption of supraspinal vasomotor pathways results in cardiovascular dysfunction following high-level spinal cord injury. To reestablish the descending regulation of autonomic function, we transplanted serotonergic neuron enriched embryonic raphe nucleus-derived neural stem cells/progenitors into the lesion site of completely transected rat spinal cord. Consequently, grafted raphe nucleus-derived neural stem cells/progenitors acted as a neuronal relay to reconnect supraspinal center and spinal sympathetic neurons below the injury. The reconstituted serotonergic regulation of sympathetic activity led to the improvement of hemodynamic parameters and mitigated autonomic dysreflexia. Based on morphological and physiological results, this study validates the effectiveness of transplanting early-stage serotonergic neurons into the spinal cord for cardiovascular functional recovery after spinal cord injury.
Copyright © 2020 the authors.

Entities:  

Keywords:  cell transplantation; hemodynamics; spinal cord transection; transsynaptic tracing

Mesh:

Year:  2020        PMID: 31896670      PMCID: PMC7002146          DOI: 10.1523/JNEUROSCI.1654-19.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Improved detection of fluorogold-labeled neurons in long-term studies.

Authors:  Mahnaz Akhavan; Thao X Hoang; Leif A Havton
Journal:  J Neurosci Methods       Date:  2005-10-24       Impact factor: 2.390

2.  A pericyte origin of spinal cord scar tissue.

Authors:  Christian Göritz; David O Dias; Nikolay Tomilin; Mariano Barbacid; Oleg Shupliakov; Jonas Frisén
Journal:  Science       Date:  2011-07-08       Impact factor: 47.728

3.  Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.

Authors:  Paul Lu; Yaozhi Wang; Lori Graham; Karla McHale; Mingyong Gao; Di Wu; John Brock; Armin Blesch; Ephron S Rosenzweig; Leif A Havton; Binhai Zheng; James M Conner; Martin Marsala; Mark H Tuszynski
Journal:  Cell       Date:  2012-09-14       Impact factor: 41.582

4.  Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.

Authors:  R M Danzebrink; G F Gebhart
Journal:  Brain Res       Date:  1991-01-04       Impact factor: 3.252

5.  Development of autonomic dysreflexia after spinal cord injury is associated with a lack of serotonergic axons in the intermediolateral cell column.

Authors:  Christen M Cormier; Karim Mukhida; Greg Walker; Daniel R Marsh
Journal:  J Neurotrauma       Date:  2010-10-06       Impact factor: 5.269

6.  Sprouting of primary afferent fibers after spinal cord transection in the rat.

Authors:  N R Krenz; L C Weaver
Journal:  Neuroscience       Date:  1998-07       Impact factor: 3.590

7.  Soluble TNFα Signaling within the Spinal Cord Contributes to the Development of Autonomic Dysreflexia and Ensuing Vascular and Immune Dysfunction after Spinal Cord Injury.

Authors:  Eugene Mironets; Patrick Osei-Owusu; Valerie Bracchi-Ricard; Roman Fischer; Elizabeth A Owens; Jerome Ricard; Di Wu; Tatiana Saltos; Eileen Collyer; Shaoping Hou; John R Bethea; Veronica J Tom
Journal:  J Neurosci       Date:  2018-04-02       Impact factor: 6.167

8.  Attenuating Neurogenic Sympathetic Hyperreflexia Robustly Improves Antibacterial Immunity After Chronic Spinal Cord Injury.

Authors:  Eugene Mironets; Roman Fischer; Valerie Bracchi-Ricard; Tatiana M Saltos; Thomas S Truglio; Micaela L O'Reilly; Kathryn A Swanson; John R Bethea; Veronica J Tom
Journal:  J Neurosci       Date:  2019-11-21       Impact factor: 6.167

9.  Transsynaptic tracing to dissect supraspinal serotonergic input regulating the bladder reflex in rats.

Authors:  Jemin Ahn; Tatiana M Saltos; Veronica J Tom; Shaoping Hou
Journal:  Neurourol Urodyn       Date:  2018-07-12       Impact factor: 2.696

10.  Spinal cord reconstitution with homologous neural grafts enables robust corticospinal regeneration.

Authors:  Ken Kadoya; Paul Lu; Kenny Nguyen; Corinne Lee-Kubli; Hiromi Kumamaru; Lin Yao; Joshua Knackert; Gunnar Poplawski; Jennifer N Dulin; Hans Strobl; Yoshio Takashima; Jeremy Biane; James Conner; Su-Chun Zhang; Mark H Tuszynski
Journal:  Nat Med       Date:  2016-03-28       Impact factor: 53.440

View more
  4 in total

Review 1.  Transneuronal tracing to map connectivity in injured and transplanted spinal networks.

Authors:  Tara A Fortino; Margo L Randelman; Adam A Hall; Jasbir Singh; David C Bloom; Esteban Engel; Daniel J Hoh; Shaoping Hou; Lyandysha V Zholudeva; Michael A Lane
Journal:  Exp Neurol       Date:  2022-01-25       Impact factor: 5.620

Review 2.  Role of Descending Serotonergic Fibers in the Development of Pathophysiology after Spinal Cord Injury (SCI): Contribution to Chronic Pain, Spasticity, and Autonomic Dysreflexia.

Authors:  Gizelle N K Fauss; Kelsey E Hudson; James W Grau
Journal:  Biology (Basel)       Date:  2022-02-01

3.  Spinal cord injury impairs cardiac function due to impaired bulbospinal sympathetic control.

Authors:  Mary P M Fossey; Shane J T Balthazaar; Jordan W Squair; Alexandra M Williams; Malihe-Sadat Poormasjedi-Meibod; Tom E Nightingale; Erin Erskine; Brian Hayes; Mehdi Ahmadian; Garett S Jackson; Diana V Hunter; Katharine D Currie; Teresa S M Tsang; Matthias Walter; Jonathan P Little; Matt S Ramer; Andrei V Krassioukov; Christopher R West
Journal:  Nat Commun       Date:  2022-03-16       Impact factor: 14.919

4.  Generation of a TPH2-EGFP reporter cell line for purification and monitoring of human serotonin neurons in vitro and in vivo.

Authors:  Ting Xu; Jinjin Duan; Yingqi Li; Guanhao Wang; Shuanqing Li; You Li; Wenting Lu; Xinyi Yan; Yixuan Ren; Fei Guo; Lining Cao; Jianfeng Lu
Journal:  Stem Cell Reports       Date:  2022-09-22       Impact factor: 7.294

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.